PREVIOUSLY TREATED, ADVANCED

Clinical trials for PREVIOUSLY TREATED, ADVANCED explained in plain language.

Never miss a new study

Get alerted when new PREVIOUSLY TREATED, ADVANCED trials appear

Sign up with your email to follow new studies for PREVIOUSLY TREATED, ADVANCED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Triple threat: drug cocktail and precision radiation take on tough bile duct cancer

Disease control Ongoing

This phase II trial tests a combination of two drugs (anlotinib and cadonilimab) plus a special type of radiation (PULSAR) in 26 people with advanced bile duct cancer that has worsened after standard treatment. The goal is to see if this triple therapy can shrink tumors and contr…

Matched conditions: PREVIOUSLY TREATED, ADVANCED

Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

PREVIOUSLY TREATED, ADVANCED

Get alerted when new PREVIOUSLY TREATED, ADVANCED trials appear

Triple threat: drug cocktail and precision radiation take on tough bile duct cancer